News

NAYA Biosciences Strengthens Board with Industry Experts

NAYA Biosciences Strengthens Board with Industry Experts

NAYA Biosciences Strengthens Board with Industry Experts

NAYA Biosciences, a dedicated player in the realm of life sciences, is making a pivotal move by nominating five new candidates for their board of directors. This decision aligns with the company's goal of accelerating its focus on groundbreaking treatments in oncology and autoimmune diseases.

The New Board Candidates

The nominees, boasting extensive experience in biotechnology, are set to be approved at the upcoming shareholder meeting. Each candidate brings a wealth of knowledge pertinent to the evolving landscape of healthcare innovations.

Laurent Audoly, PhD

Dr. Laurent Audoly is a prominent figure in the industry, serving as the cofounder and CEO of PriveBio, a company dedicated to precision medicine. His rich background includes leadership roles in R&D at major pharmaceutical firms like Pfizer and Merck, where he was instrumental in securing eight drug approvals. Holding a PhD in Pharmacology and through his pivotal work, Dr. Audoly's insights will be invaluable to NAYA.

Melissa Fensterstock, MPhil, MBA

Melissa Fensterstock joins as a seasoned strategist advising the Material Impact Fund. Her experience as CEO of Lansdowne Labs and executive roles in higher education institutions have equipped her with a deep understanding of translating academic innovations into commercial success. With degrees from Harvard Business School and the University of Cambridge, Ms. Fensterstock will enhance NAYA's strategic direction.

Prakash Raman, PhD

Dr. Prakash Raman leads InduPro, Inc., a venture-focused on protein therapeutics. His previous role as Chief Business Development Officer at Flagship Pioneering and extensive tenure at Novartis underline his exceptional capability in navigating complex collaborations and product development. His experience will broaden NAYA's strategic insights.

Daniel Teper, PharmD, MBA

As the Founder and President of NAYA Biosciences, Dr. Teper's leadership has been crucial in driving the company forward. His past leadership roles in multiple biotech firms have refined his capacity to guide innovative projects through various commercial phases. Dr. Teper's pharmacy doctorate and MBA complement his experience in the biotech sphere.

Alexandra Urman, MPH

With a robust background as an analyst and an authority in healthcare innovation, Alexandra Urman currently serves as CEO of Aomics. Her career has spanned significant roles in cancer research and investments in genomics, solidifying her knowledge and leadership within the biotechnology field. Ms. Urman’s expertise will be an asset as NAYA continues to expand.

About NAYA Biosciences

NAYA Biosciences is committed to enhancing healthcare through innovative solutions for oncology, autoimmune diseases, and women's health. Their unique hub & spoke model allows for efficient resource allocation and development of therapies, promising high returns by combining commercial success with pioneering research.

NAYA’s Innovative Portfolio

The company is advancing several promising therapeutics. Notable among them is NY-303, a bifunctional antibody targeting hepatocellular carcinoma (HCC), which seeks to address the treatment gap for a significant percentage of patients. Others in development include bifunctional antibodies aimed at multiple myeloma and diverse solid tumors, leveraging cutting-edge science to improve patient outcomes.

Contact Information

For more information or inquiries regarding NAYA Biosciences, please reach out to:

Anna Baran-Djokovic
SVP, Investor Relations
+1-305-615-9162
anna@nayabiosciences.com

Frequently Asked Questions

What is the purpose of NAYA Biosciences' new board nominations?

The new board nominations aim to leverage extensive industry expertise to drive NAYA's growth in oncology and autoimmune disease treatments.

Who are the newly nominated board members?

The nominees include industry leaders like Laurent Audoly, Melissa Fensterstock, Prakash Raman, Daniel Teper, and Alexandra Urman, each bringing unique skills and backgrounds.

What is the focus of NAYA Biosciences?

NAYA Biosciences focuses on innovative treatments for oncology, autoimmune diseases, and women’s health, seeking to improve patient care through advanced therapeutics.

How does NAYA's model contribute to its success?

NAYA employs a hub & spoke model that effectively combines shared resources and strategic agility, optimizing the development and commercialization of its therapeutic assets.

Where can I find more information about NAYA Biosciences?

For more information, contact their investor relations at the email provided. Regular updates may also be available on their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 185

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 261

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 281

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 145

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 222

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 192

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 143

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 183

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 345

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading

Top 5 Most Recently Viewed Articles

Soitec Shares Overview: Voting Rights and Capital Structure Insights

Updated Category News Views 87

Soitec, a heavyweight in the semiconductor materials game, showed some hefty figures as of late September 2024. They reported a total of 35,726,462 shares forming their share capital. But here’s where it gets interesting—these shares aren't just sitting pretty; they hold significant voting power that can shake up how things roll at the company. The Voting Rights...

Continue Reading
Market Trends: What Investors Are Reading About MELI

Updated Category News Views 194

Investors Eyeing MercadoLibre: A Look at Trading Patterns In recent weeks, a noticeable shift has occurred among large-scale investors who have taken a more cautious stance towards MercadoLibre (NASDAQ: MELI). This bearish sentiment warrants attention as it often indicates significant upcoming changes in market behavior. Options Activity: Understanding the Data Recent...

Continue Reading
Investors Urged to Act on TD Bank's Legal Matters Now

Updated Category News Views 195

Understanding the Recent Legal Challenges Facing TD Bank TD Bank, one of the largest banks in the U.S., is currently facing significant legal challenges that may impact its investors. With an investigation opened by a prominent securities law firm, the situation is evolving rapidly, and it's crucial for stakeholders to stay informed. The Circumstances Behind the Stock...

Continue Reading
Midland States Bancorp Expands Financial Service Innovations

Updated Category News Views 152

Midland States Bancorp Announces Upcoming Financial Results Midland States Bancorp, Inc. (NASDAQ: MSBI) is set to release its financial results for the third quarter of the year after market hours on a Thursday. This announcement, eagerly anticipated by investors and analysts, will be accompanied by a detailed investor presentation, ensuring stakeholders have access to...

Continue Reading
Aebi Schmidt's Stock Surges After Successful Nasdaq Launch

Updated Category News Views 331

Aebi Schmidt Celebrates Nasdaq Debut Aebi Schmidt Holding AG AEBI, known for its innovative agricultural machinery, has officially commenced its trading journey on the Nasdaq stock exchange. This follows the merger with the Shyft Group SHYF, a strategic partnership aimed at boosting their market presence. Initial Trading Performance Upon trading commencement, Aebi Schmidt...

Continue Reading